|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 310 IDR | +0.65% |
|
+1.31% | -4.91% |
| 03-31 | PT Bundamedik Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | PT Bundamedik Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
PT Bundamedik Tbk reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was IDR 1,228,664.34 million compared to IDR 1,322,960.25 million a year ago. Net income was IDR 73,726.04 million compared to IDR 192,054.02 million a year ago.
Basic earnings per share from continuing operations was IDR 9 compared to IDR 22 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.91% | 166M | |
| +20.68% | 85.55B | |
| -29.31% | 70.07B | |
| +9.23% | 29.06B | |
| -8.63% | 17.51B | |
| +2.14% | 17.39B | |
| +0.39% | 15.38B | |
| +6.47% | 13.4B | |
| +68.09% | 12.87B | |
| +6.43% | 12.77B |
PT BUNDAMEDIK TBK 